Country-Specific Regulation and International Standardization of Cell-Based Therapeutic Products Derived from Pluripotent Stem Cells

The authors outline the regulations related to PSC-derived cell-based therapeutic products in the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use founding regions, US, EU/UK, and Japan,